What you need to know about Pfizer-BioNTech vaccine
The first COVID-19 vaccine to be approved for emergency use by the World Health Organisation in December 2020, the Pfizer-BioNTech COVID-19 vaccine today is used globally in the fight against COVID-19. The Pfizer-BioNTech vaccine is also approved by Singapore’s Health Sciences Authority and is part of Singapore’s national vaccination programme.
What’s different about the Pfizer-BioNTech vaccine?
Approved for use in adolescents
Pfizer-BioNTech is one of the only COVID-19 vaccines that is approved for use in adolescents, aged 12 years and above.
First mRNA vaccine to be developed for COVID-19
Developed by German company BioNTech in partnership with Pfizer, this vaccine is the first widely-available vaccine to use mRNA technology.
Approved by 88 countries globally
The Pfizer-BioNTech vaccine is approved for use in 88 countries globally and counting.
Who is eligible for taking Pfizer-BioNTech?
|Individuals aged five years and older with:
The booster vaccine is applicable for those aged 12 years and older.
What is the recommended dosage for administration?
If you are unsure of your suitability for the vaccine, please consult your doctor first.
How safe is Pfizer-BioNTech?
Efficacy rate of 95% in preventing Covid-19 symptomatic disease in adults aged 16 years and older.